Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 17, 2025

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer
WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to …

Microchip Completes Radiation-Hardened Power MOSFET Family to MIL-PRF-19500/746 and Achieves JANSF 300 Krad Capability
CHANDLER, Ariz., April 17, 2025 (GLOBE NEWSWIRE) -- The JANS qualification represents the highest level of screening and acceptance requirements, ensuring the superior performance, quality and reliability of discrete semiconductors for aerospace, defense …

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries
ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the 2025 International Brain Injury Association World Congress …

Electrify Expo Spotlights 5 Key E-Bike Trends Driving Growth into 2025
AUSTIN, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Electrify Expo, North America’s largest electric vehicle (EV) and technology festival, is seeing major shifts in e-bike consumer trends as it gears up for another record-breaking year. With e-bike adoption …

Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025
CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, …

Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
WESTLAKE VILLAGE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report …

GSI Technology to Announce Fiscal Fourth Quarter and Year End 2025 Results on May 1, 2025
SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true …

Nametag Launches Adaptive e-ID Verification™, Integration with India’s Aadhaar National Digital Identity System
SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Nametag, the identity verification platform known for pioneering Deepfake Defense™ and Adaptive Document Verification™, today expanded its global leadership with the launch of Adaptive e-ID Verification™, a new …

Rezolve Ai to Announce Second Half and Full Year 2024 Financial Results on April 24, 2025 and Host a 2025 Business Update Conference Call on April 28, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, announces that the Company will report second half and full year 2024 financial results on Thursday, April 24, 2025 after market …

authID Joins the Secure Technology Alliance to Advance the Development of Global Identity Standards Across Authentication Technologies
This membership underscores commitment to enhancing data protection and user privacy through industry collaboration DENVER, COLORADO, April 17, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID), a leading provider of biometric identity verification and …

Beghou Consulting Names Award-Winning Artificial Intelligence Executive, Thought Leader, and Inventor as New VP, AI Innovation
EVANSTON, Ill., April 17, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions to life sciences companies, today announced that acclaimed artificial intelligence (AI) and machine learning leader …

Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer
CARLSBAD, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of Chris M. Storgard, M.D …

Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans
LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it’s Cell Pouch Bio-hybrid Organ as a functional cure for type …

Tilray Medical Introduces Cannabis Edibles in Australia
SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners …

CareCloud to Announce First Quarter 2025 Results on May 6, 2025
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first …

Infinidat Recognized on the CRN® Storage 100 List for the Sixth Consecutive Year; Recognized as One of 2025’s 50 Coolest Software-Defined Storage Vendors
WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that CRN®, a brand of The Channel Company, has included Infinidat on the 2025 CRN Storage 100 list in the Software Defined …

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
-- Retrospective analysis reveals no significant differences in comorbidities in narcolepsy patients treated vs. not treated with sodium oxybate -- -- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most …

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors
SAN DIEGO, April 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug Administration (FDA) …

Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
--76-week trial is evaluating the safety and efficacy of a progranulin-elevating candidate in slowing disease progression-- --Enrollment completed ahead of schedule-- SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: …

Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23
GAITHERSBURG, Md., April 17, 2025 (GLOBE NEWSWIRE) -- Bullfrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …